- Home
- SCNI vs AQB Comparison
SCNI vs AQB Comparison
Compare SCNI & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- AQB
- Stock Information
- Founded
- SCNI 2003
- AQB 1991
- Country
- SCNI Israel
- AQB United States
- Employees
- SCNI N/A
- AQB N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- AQB
- Sector
- SCNI Health Care
- AQB
- Exchange
- SCNI Nasdaq
- AQB Nasdaq
- Market Cap
- SCNI 3.1M
- AQB 3.0M
- IPO Year
- SCNI N/A
- AQB N/A
- Fundamental
- Price
- SCNI $3.51
- AQB $0.79
- Analyst Decision
- SCNI
- AQB Hold
- Analyst Count
- SCNI 0
- AQB 2
- Target Price
- SCNI N/A
- AQB N/A
- AVG Volume (30 Days)
- SCNI 8.1K
- AQB 1.3M
- Earning Date
- SCNI 11-22-2024
- AQB 11-05-2024
- Dividend Yield
- SCNI N/A
- AQB N/A
- EPS Growth
- SCNI N/A
- AQB N/A
- EPS
- SCNI 8.20
- AQB N/A
- Revenue
- SCNI $452,000.00
- AQB $1,258,512.00
- Revenue This Year
- SCNI N/A
- AQB N/A
- Revenue Next Year
- SCNI N/A
- AQB $57.38
- P/E Ratio
- SCNI $0.43
- AQB N/A
- Revenue Growth
- SCNI N/A
- AQB N/A
- 52 Week Low
- SCNI $2.23
- AQB $0.47
- 52 Week High
- SCNI $8.92
- AQB $2.79
- Technical
- Relative Strength Index (RSI)
- SCNI 52.75
- AQB 52.43
- Support Level
- SCNI $3.41
- AQB $0.69
- Resistance Level
- SCNI $3.80
- AQB $0.87
- Average True Range (ATR)
- SCNI 0.18
- AQB 0.10
- MACD
- SCNI -0.00
- AQB 0.02
- Stochastic Oscillator
- SCNI 36.42
- AQB 72.11
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.